NCT07532954

Brief Summary

To learn about the effects of a participant support community on illness perception, emotional well-being, and feelings of isolation among participants with NECC.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
31mo left

Started Apr 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

April 13, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 16, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2028

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

April 13, 2026

Last Update Submit

April 15, 2026

Conditions

Neuroendocrine Cervical CancerPatient Support

Outcome Measures

Primary Outcomes (1)

  • Demographic questionnaire

    This questionnaire will collect basic information including age, marital status, number of children, disease stage at diagnosis, and current disease status and treatment.

    Through study completion; an average of 1 year

Study Arms (1)

Focus Group

participants will take part in a focus group session to share their personal experiences

Other: Questionnaire

Interventions

QuestionnaireOTHER

Demographic questionnaire

Focus Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MD Anderson Cancer Center

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MD Anderson Cancer Center

Houston, Texas, 77044, United States

RECRUITING

Related Links

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Larissa Meyer, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Larissa Meyer, MD

CONTACT

Meyerlmeyer@mdanderson.org

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 16, 2026

Study Start

April 13, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2028

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations

US(1)